This article was nominated for deletion. The discussion was closed on 23 December 2023 with a consensus to merge the content into the article Propranolol. If you find that such action has not been taken promptly, please consider assisting in the merger instead of re-nominating the article for deletion. To discuss the merger, please use the destination article's talk page. (December 2023)
The topic of this article may not meet Wikipedia's notability guidelines for products and services. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted.Find sources: "Idropranolol" – news · newspapers · books · scholar · JSTOR (August 2020) (Learn how and when to remove this template message)
Idropranolol
Clinical data
ATC code
  • None
Legal status
Legal status
  • Never marketed
Identifiers
  • 1-(5,6-Dihydro-1-naphthalenyloxy)-3-(isopropylamino)-2-propanol
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC16H23NO2
Molar mass261.365 g·mol−1
3D model (JSmol)
  • CC(C)NCC(COC1=CC=CC2=C1C=CCC2)O
  • InChI=1S/C16H23NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h4-5,7-9,12,14,17-18H,3,6,10-11H2,1-2H3
  • Key:JKLYFQUDQSQWRB-UHFFFAOYSA-N

Idropranolol is a beta blocker that was never marketed.[1][2]

References

  1. ^ Morton IK, Hall JM (Oct 31, 1999). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer. p. 150.
  2. ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 676. ISBN 978-1-4757-2085-3.
Categories